Alberto M. Borobia

4.1k total citations
104 papers, 1.5k citations indexed

About

Alberto M. Borobia is a scholar working on Pharmacology, Pediatrics, Perinatology and Child Health and Infectious Diseases. According to data from OpenAlex, Alberto M. Borobia has authored 104 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Pharmacology, 24 papers in Pediatrics, Perinatology and Child Health and 22 papers in Infectious Diseases. Recurrent topics in Alberto M. Borobia's work include Pharmacogenetics and Drug Metabolism (25 papers), Pharmaceutical studies and practices (10 papers) and Pharmacological Effects and Toxicity Studies (10 papers). Alberto M. Borobia is often cited by papers focused on Pharmacogenetics and Drug Metabolism (25 papers), Pharmaceutical studies and practices (10 papers) and Pharmacological Effects and Toxicity Studies (10 papers). Alberto M. Borobia collaborates with scholars based in Spain, Italy and United States. Alberto M. Borobia's co-authors include Antonio J. Carcas, Elena Ramı́rez, Jesús Frías, Hoi Y. Tong, Francisco Abad‐Santos, Salvador Fudio, Irene García-García, Miriam Saiz‐Rodríguez, Juan Carlos Figueira and Dolores Ochoa and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Alberto M. Borobia

95 papers receiving 1.5k citations

Peers

Alberto M. Borobia

PHARM

PPCH

PHARM

Mordechai Muszkat Israel

Kyoung Soo Lim South Korea

Jacqueline B. McCrea United States

Masato Homma Japan

Jung Mi Oh South Korea

Caroline Samer Switzerland

Domenico Motola Italy

Yukinao Kohda Japan

Shin Irie Japan

Stefan Russmann Switzerland

Mordechai Muszkat Israel

Alberto M. Borobia

550 ×1.4

PHARM

212 ×0.8

PPCH

214 ×0.8

186 ×0.8

PHARM

332 ×1.8

Citations per year, relative to Alberto M. Borobia Alberto M. Borobia (= 1×) peers Mordechai Muszkat

Countries citing papers authored by Alberto M. Borobia

Since Specialization

Citations

This map shows the geographic impact of Alberto M. Borobia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alberto M. Borobia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alberto M. Borobia more than expected).

Fields of papers citing papers by Alberto M. Borobia

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alberto M. Borobia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alberto M. Borobia. The network helps show where Alberto M. Borobia may publish in the future.

Co-authorship network of co-authors of Alberto M. Borobia

This figure shows the co-authorship network connecting the top 25 collaborators of Alberto M. Borobia. A scholar is included among the top collaborators of Alberto M. Borobia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alberto M. Borobia. Alberto M. Borobia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tung‐Chen, Yale, Paloma Oliver, Antonio Buño Soto, et al.. (2025). Efficacy of a fast-track pathway for managing uncomplicated renal or ureteral colic in a hospital emergency department: the STONE randomized clinical trial of Sonography and Testing of a Nephrolithiasis Episode. Emergencias. 33(1). 23–28.

Borobia, Alberto M., et al.. (2025). The READI European project: Enhancing inclusivity in clinical research. European Journal of Clinical Investigation. 56(1). e70146–e70146.

Stewart, Stefan, et al.. (2024). ALDRESS: A Retrospective Pilot Study to Develop a Pharmacological Causality Algorithm for Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS). Journal of Clinical Medicine. 13(9). 2622–2622. 2 indexed citations

Conradie, Almari, Uwe Fuhr, Francisco Abad‐Santos, et al.. (2023). Academia and industry agreement on a feasibility tool for first‐time‐in‐human clinical trial units. Clinical and Translational Science. 16(12). 2421–2428. 1 indexed citations

Carpio, Carlos, Antonio Buño Soto, Alberto M. Borobia, et al.. (2023). Krebs von den Lungen-6 (KL-6) Levels in Post-COVID Follow-Up: Differences According to the Severity of COVID-19. Journal of Clinical Medicine. 12(19). 6299–6299. 2 indexed citations

Urroz, Mikel, et al.. (2023). Evaluation of factors associated with recruitment rates in early phase clinical trials based on the European Clinical Trials Register data. Clinical and Translational Science. 16(12). 2654–2664. 1 indexed citations

Montejano, Rocío, et al.. (2023). The Current Mismatch Between COVID-19 Clinical Trial Design and the Evolving Profile of Hospitalized Patients: A Retrospective Cohort Analysis. Clinical Infectious Diseases. 78(4). 918–921. 1 indexed citations

Borobia, Alberto M., et al.. (2023). Clinical research with targeted drugs in paediatric oncology. Drug Discovery Today. 28(8). 103672–103672. 3 indexed citations

Würthwein, Gudrun, Pablo Zubiaur, Bianca Posocco, et al.. (2022). Population pharmacokinetic modelling of imatinib in healthy subjects receiving a single dose of 400 mg. Cancer Chemotherapy and Pharmacology. 90(2). 125–136. 4 indexed citations

10.

Villatoro, Jaime Monserrat, Gina Mejía‐Abril, Pablo Zubiaur, et al.. (2022). A Case-Control of Patients with COVID-19 to Explore the Association of Previous Hospitalisation Use of Medication on the Mortality of COVID-19 Disease: A Propensity Score Matching Analysis. Pharmaceuticals. 15(1). 78–78. 5 indexed citations

11.

Celis, Elena de, Blanca Fuentes, Francisco Moniche, et al.. (2021). Allogeneic adipose tissue-derived mesenchymal stem cells in ischaemic stroke (AMASCIS-02): a phase IIb, multicentre, double-blind, placebo-controlled clinical trial protocol. BMJ Open. 11(8). e051790–e051790. 18 indexed citations

12.

Borobia, Alberto M., Irene García-García, Lucía Martínez de Soto, et al.. (2021). Health Care Workers’ Reasons for Choosing Between Two Different COVID-19 Prophylaxis Trials in an Acute Pandemic Context: Single-Center Questionnaire Study. Journal of Medical Internet Research. 23(2). e23441–e23441. 2 indexed citations

13.

García-García, Irene, Cristina Ferreras, Alberto M. Borobia, et al.. (2021). A phase I/II dose-escalation multi-center study to evaluate the safety of infusion of natural killer cells or memory T cells as adoptive therapy in coronavirus pneumonia and/or lymphopenia: RELEASE study protocol. Trials. 22(1). 674–674. 5 indexed citations

14.

Pena, Maria, Javier Muriel, Miriam Saiz‐Rodríguez, et al.. (2020). Effect of Cytochrome P450 and ABCB1 Polymorphisms on Imatinib Pharmacokinetics After Single-Dose Administration to Healthy Subjects. Clinical Drug Investigation. 40(7). 617–628. 16 indexed citations

15.

Dapía, Irene, Marta Melgosa, Á. Alonso Melgar, et al.. (2017). Effect of the CYP3A5, CYP3A4, CYP3A7, ABCB1, POR and NR1I2 genes in the pharmacokinetics of tacrolimus in a pediatric cohort with stable serum concentrations after renal transplantation: study protocol.. SHILAP Revista de lepidopterología. 1 indexed citations

16.

Borobia, Alberto M. & Antonio J. Carcas. (2016). Implementación de la farmacogenética en la práctica clínica: hacia las estrategias de genotipado anticipado. SHILAP Revista de lepidopterología. 1(1). 2 indexed citations

17.

Martín‐Quirós, Alejandro, et al.. (2015). Mortalidad en el traumatismo potencialmente grave atendido en un servicio de urgencias de tercer nivel: Evaluación de la escala pronóstico de mortalidad GAP. Emergencias. 27(6). 371–374. 1 indexed citations

18.

Quintana‐Díaz, Manuel, et al.. (2014). Experiencia del uso de los concentrados de complejo protrombínico en un servicio de urgencias hospitalario. Emergencias. 26(4). 303–306. 1 indexed citations

19.

Borobia, Alberto M., et al.. (2013). Desarrollo y validación de un programa de toxicovigilancia con detección automatizada de casos en un hopital terciario (SAT-HULP). Emergencias. 25(6). 423–429. 3 indexed citations

20.

Quintana‐Díaz, Manuel, et al.. (2012). Estudio de coste-efectividad del empleo de concentrado de complejo protrombínico en urgencias para evitar las complicaciones de la sobredosificación de anticoagulantes. Emergencias. 24(2). 113–120. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact